Related Experiment Video

Updated: Aug 21, 2026

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
06:27

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

Published on: August 8, 2019

Novel peptide ligands for integrin alpha 4 beta 1 overexpressed in cancer cells

Masahito Mikawa1, Henry Wang, Linlang Guo

  • 1University of California at Davis Cancer Center, 4501 X Street, Sacramento, CA 95817, USA.

Molecular Cancer Therapeutics
|October 16, 2004
PubMed

Insights

Researchers identified novel cyclic peptides that promote the attachment and proliferation of specific cancer cells, including bronchioloalveolar carcinoma. These peptide ligands target integrin alpha(4)beta(1), offering potential for targeted cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Development of targeted therapies for bronchioloalveolar carcinoma and lymphoid cancers is crucial.
  • Understanding cell-surface receptor interactions is key to designing effective treatments.

Purpose of the Study:

  • To synthesize and screen a library of cyclic peptides for their ability to promote cancer cell attachment and proliferation.
  • To identify specific peptide sequences and their corresponding cellular receptors.

Main Methods:

  • Utilized "one-bead one-peptide" combinatorial technology to synthesize a diverse peptide library.
  • Employed a "cell growth on bead" assay to screen for peptides promoting H1650 cell growth.
  • Performed alanine scanning, site-directed deletion, antibody blocking, and cell transfection assays to characterize ligands and receptors.

Main Results:

  • Identified consensus cyclic peptide sequences (cNleDXXXXc and cXNleDXXXXc) promoting H1650 cell attachment and proliferation.
  • Discovered peptide specificity for H1650, Jurkat, and Raji cells, but not other tested cell lines.
  • Determined integrin alpha(4)beta(1) as the putative receptor, with a critical binding site at glycine residue 190 of integrin alpha(4).

Conclusions:

  • Novel cyclic peptides act as specific ligands for integrin alpha(4)beta(1) on certain cancer cells.
  • These findings provide a foundation for developing targeted peptide-based therapeutics for bronchioloalveolar carcinoma and lymphoid malignancies.

More Related Videos

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

Published on: January 7, 2019

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on: February 2, 2024

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...